PT - JOURNAL ARTICLE AU - Staub, Kaspar AU - Panczak, Radoslaw AU - Matthes, Katarina L. AU - Floris, Joël AU - Berlin, Claudia AU - Junker, Christoph AU - Weitkunat, Rolf AU - Mamelund, Svenn-Erik AU - Egger, Matthias AU - Zwahlen, Marcel AU - Riou, Julien TI - Pandemic excess mortality in Spain, Sweden, and Switzerland during the COVID-19 pandemic in 2020 was at its highest since 1918 AID - 10.1101/2021.08.12.21261825 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.12.21261825 4099 - http://medrxiv.org/content/early/2021/08/13/2021.08.12.21261825.short 4100 - http://medrxiv.org/content/early/2021/08/13/2021.08.12.21261825.full AB - Estimating excess mortality allows quantification of overall pandemic impact. For recent decades, mortality data are easily accessible for most industrialized countries, but only a few countries have continuous data available for longer periods. Since Spain, Sweden, and Switzerland were militarily neutral and not involved in combat during both world wars, these countries have monthly all-cause mortality statistics available for over 100 years with no interruptions. We show that during the COVID-19 pandemic in 2020, Spain, Sweden and Switzerland recorded the highest aggregated monthly excess mortality (17%, 9% and 14%) since the 1918 influenza pandemic (53%, 33% and 49%), when compared to respective expected values. For Sweden and Switzerland, the highest monthly spikes in 2020 almost reached those of January 1890. These findings emphasize the historical dimensions of the ongoing pandemic and support the notion of a pandemic disaster memory gap.One-Sentence Summary During the COVID-19 pandemic in 2020, Spain, Sweden, and Switzerland recorded their highest monthly excess and all-cause mortality levels since the 1918 influenza pandemic, emphasizing the historical dimension of the ongoing pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Foundation for Research in Science and the Humanities at the University of Zurich (grant STWF-21-011, grantees K.S. and J.F.) and the Swiss National Science Foundation (SNSF project number 189498, grantee M.E.). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study re-uses publicly available and monthly aggregated mortality figures at the national level, published by the national statistical authorities. Therefore, ethics approval was not necessary in this case.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code used in this analysis are provided here: https://github.com/RPanczak/ISPM_excess-mortality/. https://github.com/RPanczak/ISPM_excess-mortality/